摘要
The serologic markers of the therapeutic response of chronic necrotizing pulmonary aspergillosis (CNPA) are rarely reported. Here, we describe the changes in galactomannan (GM) antigenemia in a patient receiving oral voriconazole for CNPA, in whom a resolution of GM antigenemia to a normal level was associated with clinical improvements. The serum GM index can be an adjunctive tool for the diagnosis and monitoring of the therapeutic response of CNPA.
原文 | English |
---|---|
頁(從 - 到) | 528-530 |
頁數 | 3 |
期刊 | Diagnostic Microbiology and Infectious Disease |
卷 | 70 |
發行號 | 4 |
DOIs | |
出版狀態 | Published - 2011 8月 |
All Science Journal Classification (ASJC) codes
- 微生物學(醫學)
- 傳染性疾病